146 related articles for article (PubMed ID: 2667871)
21. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
22. Effect of naturally reduced ovarian function on plasma lipoprotein and 27-hydroxycholesterol levels in baboons (Papio sp.).
Chen LD; Kushwaha RS; McGill HC; Rice KS; Carey KD
Atherosclerosis; 1998 Jan; 136(1):89-98. PubMed ID: 9544735
[TBL] [Abstract][Full Text] [Related]
23. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
24. Dimeric inhibin: a direct marker of ovarian aging.
Danforth DR; Arbogast LK; Mroueh J; Kim MH; Kennard EA; Seifer DB; Friedman CI
Fertil Steril; 1998 Jul; 70(1):119-23. PubMed ID: 9660432
[TBL] [Abstract][Full Text] [Related]
25. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
Parker CR; Mahesh VB
J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrinology of menopause.
Dasgupta A; Rehman HU
Minerva Ginecol; 2006 Feb; 58(1):25-33. PubMed ID: 16498368
[TBL] [Abstract][Full Text] [Related]
27. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
28. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
29. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
[TBL] [Abstract][Full Text] [Related]
30. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761
[TBL] [Abstract][Full Text] [Related]
31. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
32. Changes of ovarian hormonal function with aging.
Judd HL; Fournet N
Exp Gerontol; 1994; 29(3-4):285-98. PubMed ID: 7925749
[TBL] [Abstract][Full Text] [Related]
33. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
34. [The acute feedback action of exogenously administered oestrogens on the serum-gonadotropin-levels in pre- and postmenopausal women (author's transl)].
Czygan PJ; Reich W
Arch Gynakol; 1973 May; 215(1):17-38. PubMed ID: 4582609
[TBL] [Abstract][Full Text] [Related]
35. Non-reproductive Effects of Anovulation: Bone Metabolism in the Luteal Phase of Premenopausal Women Differs between Ovulatory and Anovulatory Cycles.
Niethammer B; Körner C; Schmidmayr M; Luppa PB; Seifert-Klauss VR
Geburtshilfe Frauenheilkd; 2015 Dec; 75(12):1250-1257. PubMed ID: 26726266
[No Abstract] [Full Text] [Related]
36. Revisiting the cutaneous impact of oral hormone replacement therapy.
Piérard GE; Humbert P; Berardesca E; Gaspard U; Hermanns-Lê T; Piérard-Franchimont C
Biomed Res Int; 2013; 2013():971760. PubMed ID: 24455744
[TBL] [Abstract][Full Text] [Related]
37. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
Anderson RA; Groome NP; Baird DT
Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
[TBL] [Abstract][Full Text] [Related]
38. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
Sherman BM; West JH; Korenman SG
J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
[TBL] [Abstract][Full Text] [Related]
39. Changes in lipoproteins with various sex steroids.
Teran AZ; Greenblatt RB; Chaddha JS
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
[TBL] [Abstract][Full Text] [Related]
40. Menopausal endocrinology and management.
Korenman SG
Arch Intern Med; 1982 Jun; 142(6):1131-6. PubMed ID: 7046670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
